Should I buy or sell DocGo stock right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for DocGo in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" DCGO shares. View DCGO analyst ratings or view top-rated stocks .

What is DocGo's stock price target for 2024?

4 brokers have issued 1 year target prices for DocGo's shares. Their DCGO share price targets range from $12.00 to $16.00. On average, they expect the company's share price to reach $13.60 in the next year. This suggests a possible upside of 148.2% from the stock's current price. View analysts price targets for DCGO or view top-rated stocks among Wall Street analysts .

How have DCGO shares performed in 2023?

DocGo's stock was trading at $7.07 at the beginning of the year. Since then, DCGO stock has decreased by 22.5% and is now trading at $5.48. View the best growth stocks for 2023 here .

Are investors shorting DocGo?

DocGo saw a drop in short interest in the month of November. As of November 15th, there was short interest totaling 9,380,000 shares, a drop of 5.3% from the October 31st total of 9,900,000 shares. Based on an average trading volume of 1,040,000 shares, the short-interest ratio is currently 9.0 days. Currently, 10.7% of the company's stock are sold short. View DocGo's Short Interest .

When is DocGo's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, March 11th 2024. View our DCGO earnings forecast .

How were DocGo's earnings last quarter?

DocGo Inc. (NASDAQ:DCGO) released its earnings results on Monday, November, 6th. The company reported $0.05 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.07 by $0.02. The company earned $186.55 million during the quarter, compared to the consensus estimate of $145.64 million. DocGo had a trailing twelve-month return on equity of 3.11% and a net margin of 1.38%.

What ETFs hold DocGo's stock?

ETFs with the largest weight of DocGo (NASDAQ:DCGO) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC) . iShares U.S. Healthcare Providers ETF (IHF) .

Who are DocGo's major shareholders?

DocGo's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Deerfield Management Company L.P. Series C (4.59%), Emerald Advisers LLC (2.32%), WCM Investment Management LLC (2.15%), Punch & Associates Investment Management Inc. (1.98%), Emerald Mutual Fund Advisers Trust (1.84%) and Kennedy Capital Management LLC (1.80%). Insiders that own company stock include Adriaan Stephanus Oberholzer, Anthony Capone, Ely D Tendler, James M Travers, Lee Bienstock and Stephen Sugrue. View institutional ownership trends .

How do I buy shares of DocGo?

Shares of DCGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull , Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here .

DocGo Stock Price, News & Analysis (NASDAQ:DCGO)

$5.48

-0.08 (-1.44%)

(As of 12/6/2023 ET)

Compare

Today's Range: $5.47
▼
$5.74
50-Day Range: $5.13
▼
$6.75
52-Week Range: $4.88
▼
$10.82

Volume: 1.04 million shs
Average Volume: 785,625 shs
Market Capitalization: $569.35 million

P/E Ratio: 60.89
Dividend Yield: N/A
Price Target: $13.60

DocGo MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 148.2% Upside
$13.60 Price Target
Short Interest: Healthy
10.72% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.50
Based on 7 Articles This Week
Insider Trading: Selling Shares
$148,793 Sold Last Quarter
Proj. Earnings Growth: 512.50%
From $0.08 to $0.49 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.75 out of 5 stars

Medical Sector

78th out of 957 stocks

Health Services Industry

3rd out of 12 stocks

3.5

Analyst's Opinion

Consensus Rating
DocGo has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $13.60, DocGo has a forecasted upside of 148.2% from its current price of $5.48.
Amount of Analyst Coverage
DocGo has only been the subject of 4 research reports in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
10.72% of the float of DocGo has been sold short.
Short Interest Ratio / Days to Cover
DocGo has a short interest ratio ("days to cover") of 9.
Change versus previous month
Short interest in DocGo has recently decreased by 5.25%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
DocGo does not currently pay a dividend.
Dividend Growth
DocGo does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for DCGO.

2.5

News and Social Media Coverage

News Sentiment
DocGo has a news sentiment score of 0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
News Coverage This Week
MarketBeat has tracked 7 news articles for DocGo this week, compared to 3 articles on an average week.
Search Interest
5 people have searched for DCGO on MarketBeat in the last 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, DocGo insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $148,793.00 in company stock.
Percentage Held by Insiders
13.78% of the stock of DocGo is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
52.14% of the stock of DocGo is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

3.1

Earnings and Valuation

Earnings Growth
Earnings for DocGo are expected to grow by 512.50% in the coming year, from $0.08 to $0.49 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of DocGo is 60.89, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 116.44.
Price to Earnings Ratio vs. Sector
The P/E ratio of DocGo is 60.89, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 106.64.
Price to Book Value per Share Ratio
DocGo has a P/B Ratio of 2.01. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About DocGo Stock (NASDAQ:DCGO)

DocGo Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home and offices; testing; vaccinations; and event services, which include on-site healthcare support at sporting events and concerts. DocGo Inc. was incorporated in 2015 and is based in New York, New York.

DCGO Stock Price History

30 days | 90 days | 365 days | Advanced Chart

DCGO Stock News Headlines

December 6, 2023 | markets.businessinsider.com

SHAREHOLDER ALERT: Potential Recovery for DocGo Inc. (DCGO) Investors Affected by Stock Drop – Levi & Korsinsky Pursuing Class Action Lawsuit

December 4, 2023 | americanbankingnews.com

Short Interest in DocGo Inc. (NASDAQ:DCGO) Decreases By 5.3%

December 7, 2023 | Financial Alphas (Ad)

Lithium Discovery So BIG You Can't Miss it, Even From Space

With the green energy transition well underway, lithium demand is rapidly outpacing projected supply. While companies frantically search for new sources of this critical metal, one small company is sitting on a massive claim in North America - So big in fact that it can clearly be seen from space!

December 3, 2023 | barrons.com

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in DocGo Inc. with Losses In Excess of $100,000 to Contact the Firm

November 30, 2023 | markets.businessinsider.com

Analysts Are Bullish on Top Healthcare Stocks: Henry Schein (HSIC), DocGo (DCGO)

November 30, 2023 | seekingalpha.com

DocGo: Growth Significantly Exceeded My Expectations

November 30, 2023 | finance.yahoo.com

DocGo Inc. (NASDAQ:DCGO) is largely controlled by institutional shareholders who own 59% of the company

November 29, 2023 | benzinga.com

DocGo Stock (NASDAQ:DCGO), Analyst Ratings, Price Targets, Predictions

December 7, 2023 | Financial Alphas (Ad)

Lithium Discovery So BIG You Can't Miss it, Even From Space

November 29, 2023 | americanbankingnews.com

DocGo (NASDAQ:DCGO) Rating Reiterated by Stifel Nicolaus

November 28, 2023 | benzinga.com

DocGo Inc. investors: Please contact the Portnoy...

November 28, 2023 | barrons.com

DocGo Sued for Securities Law Violations; Investors Should Contact Block & Leviton for More Information

November 27, 2023 | barrons.com

DCGO Class Action Alert: Bronstein, Gewirtz & Grossman LLC Reminds DocGo Inc Investors with Substantial Losses to Contact the Firm!

November 27, 2023 | markets.businessinsider.com

7 Analysts Have This to Say About DocGo

November 24, 2023 | markets.businessinsider.com

SHAREHOLDER ALERT: Potential Recovery for DocGo Inc. (DCGO) Investors Affected by Stock Drop - Levi & Korsinsky Pursuing Class Action Lawsuit

November 22, 2023 | benzinga.com

DCGO Investors Have Opportunity to Lead DocGo Inc. Securities Fraud Lawsuit

November 22, 2023 | barrons.com

INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in DocGo Inc. with Losses of $100,000 to Contact the Firm

November 22, 2023 | barrons.com

SHAREHOLDER ALERT: Levi & Korsinsky Notifies DocGo Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - DCGO

November 20, 2023 | businesswire.com

DCGO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that DocGo Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

November 19, 2023 | barrons.com

INVESTOR ALERT: Levi & Korsinsky Notifies Shareholders of DocGo Inc.(DCGO) of a Class Action Lawsuit and an Upcoming Deadline

November 18, 2023 | benzinga.com

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages DocGo Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DCGO

November 17, 2023 | barrons.com

DocGo Shareholder Alert

November 14, 2023 | benzinga.com

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against DocGo Inc. (DCGO)

November 14, 2023 | businesswire.com

DCGO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that DocGo Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

November 14, 2023 | businesswire.com

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against DocGo Inc. (DCGO)

November 14, 2023 | barrons.com

INVESTOR ALERT: Potential Recovery for DocGo Inc. (DCGO) Investors Affected by Stock Drop -- Levi & Korsinsky Pursuing Class Action Lawsuit

November 12, 2023 | markets.businessinsider.com

DocGo Ongoing Deadline Alert

See More Headlines

Receive DCGO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DocGo and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/06/2023
Today: 12/06/2023
Fiscal Year End: 12/31/2023
Next Earnings (Estimated): 3/11/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health services
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:DCGO
CUSIP: N/A
CIK: 1822359
Web: www.docgo.com
Phone: 844-443-6246
Fax: N/A
Employees: 3,252
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $13.60
High Stock Price Target: $16.00
Low Stock Price Target: $12.00
Potential Upside/Downside: +148.2%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 4 Analysts

Profitability

EPS (Most Recent Fiscal Year): $0.09
Trailing P/E Ratio: 60.89
Forward P/E Ratio: 68.50
P/E Growth: N/A
Net Income: $34.58 million
Net Margins: 1.38%
Pretax Margin: 0.40%
Return on Equity: 3.11%
Return on Assets: 2.20%

Debt

Debt-to-Equity Ratio: 0.01
Current Ratio: 2.36
Quick Ratio: 2.36

Sales & Book Value

Annual Sales: $533.83 million
Price / Sales: 1.07
Cash Flow: $0.42 per share
Price / Cash Flow: 13.12
Book Value: $2.72 per share
Price / Book: 2.01

Miscellaneous

Outstanding Shares: 103,896,000
Free Float: 89,579,000
Market Cap: $569.35 million
Optionable: Not Optionable
Beta: 0.92

13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

Mr. Stan Vashovsky (Age 50)
Co-Founder & Non-Executive Chairman
Comp: $2.45M
Mr. Lee Bienstock (Age 39)
Chief Executive Officer
Comp: $1.24M
Mr. Ely D. Tendler (Age 55)
General Counsel, Secretary & Director
Mr. Norman Rosenberg (Age 53)
Treasurer & CFO
Mike Cole
Vice President of Investor Relations
Mr. Stephen Sugrue (Age 51)
Chief Compliance Officer
Mr. Ben Sherman
EVP of Corporate Development
Ms. Rosemarie Milano
Vice President of Human Resources
Mr. Andre Oberholzer CPA (Age 65)
Executive Vice President of Strategy
Comp: $1.75M
Mr. Aaron Severs
Chief Product Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

DCGO Stock Analysis - Frequently Asked Questions

Should I buy or sell DocGo stock right now?: 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for DocGo in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" DCGO shares.
View DCGO analyst ratings or view top-rated stocks.
What is DocGo's stock price target for 2024?: 4 brokers have issued 1 year target prices for DocGo's shares. Their DCGO share price targets range from $12.00 to $16.00. On average, they expect the company's share price to reach $13.60 in the next year. This suggests a possible upside of 148.2% from the stock's current price.
View analysts price targets for DCGO or view top-rated stocks among Wall Street analysts.
How have DCGO shares performed in 2023?: DocGo's stock was trading at $7.07 at the beginning of the year. Since then, DCGO stock has decreased by 22.5% and is now trading at $5.48.
View the best growth stocks for 2023 here.
Are investors shorting DocGo?: DocGo saw a drop in short interest in the month of November. As of November 15th, there was short interest totaling 9,380,000 shares, a drop of 5.3% from the October 31st total of 9,900,000 shares. Based on an average trading volume of 1,040,000 shares, the short-interest ratio is currently 9.0 days. Currently, 10.7% of the company's stock are sold short.
View DocGo's Short Interest.
When is DocGo's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, March 11th 2024.
View our DCGO earnings forecast.

How were DocGo's earnings last quarter?: DocGo Inc. (NASDAQ:DCGO) released its earnings results on Monday, November, 6th. The company reported $0.05 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.07 by $0.02. The company earned $186.55 million during the quarter, compared to the consensus estimate of $145.64 million. DocGo had a trailing twelve-month return on equity of 3.11% and a net margin of 1.38%.
What ETFs hold DocGo's stock?: ETFs with the largest weight of DocGo (NASDAQ:DCGO) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC).iShares U.S. Healthcare Providers ETF (IHF).
Who are DocGo's major shareholders?: DocGo's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Deerfield Management Company L.P. Series C (4.59%), Emerald Advisers LLC (2.32%), WCM Investment Management LLC (2.15%), Punch & Associates Investment Management Inc. (1.98%), Emerald Mutual Fund Advisers Trust (1.84%) and Kennedy Capital Management LLC (1.80%). Insiders that own company stock include Adriaan Stephanus Oberholzer, Anthony Capone, Ely D Tendler, James M Travers, Lee Bienstock and Stephen Sugrue.
View institutional ownership trends.
How do I buy shares of DocGo?: Shares of DCGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:DCGO) was last updated on 12/7/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial